What is she best known for?
The fields of study she is best known for:
- Gene
- Cancer
- Internal medicine
Her main research concerns Myeloid leukemia, Leukemia, Internal medicine, Cancer research and Immunology.
Her Myeloid leukemia research includes themes of Cancer, Enasidenib, Gene expression profiling, Myelodysplastic syndromes and NPM1.
Her Leukemia study integrates concerns from other disciplines, such as Myeloid, BAALC, Cytogenetics and Fms-Like Tyrosine Kinase 3.
Her work carried out in the field of Internal medicine brings together such families of science as Gastroenterology, Surgery and Oncology.
Her Cancer research research incorporates elements of Mutation, Germline mutation, Somatic evolution in cancer, Regulation of gene expression and Genetic heterogeneity.
Her research integrates issues of Acute promyelocytic leukemia, Retinoic acid, Stem cell and Janus kinase 2 in her study of Immunology.
Her most cited work include:
- Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia (2729 citations)
- Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. (2498 citations)
- Genomic Classification and Prognosis in Acute Myeloid Leukemia (1566 citations)
What are the main themes of her work throughout her whole career to date?
Konstanze Döhner mainly investigates Myeloid leukemia, Internal medicine, Cancer research, Leukemia and Oncology.
The various areas that Konstanze Döhner examines in her Myeloid leukemia study include Myeloid, Molecular biology, NPM1 and Gene expression profiling.
Her work in Internal medicine covers topics such as Gene mutation which are related to areas like Neuroblastoma RAS viral oncogene homolog.
In her research on the topic of Cancer research, Progenitor cell is strongly related with Haematopoiesis.
Konstanze Döhner interconnects Acute promyelocytic leukemia, Adult Acute Myeloid Leukemia, Bone marrow and Survival rate in the investigation of issues within Leukemia.
Her biological study spans a wide range of topics, including Bioinformatics, Midostaurin, Hematology, Cumulative incidence and Hazard ratio.
She most often published in these fields:
- Myeloid leukemia (49.35%)
- Internal medicine (42.64%)
- Cancer research (30.52%)
What were the highlights of her more recent work (between 2017-2021)?
- Internal medicine (42.64%)
- Myeloid leukemia (49.35%)
- Oncology (26.84%)
In recent papers she was focusing on the following fields of study:
Her scientific interests lie mostly in Internal medicine, Myeloid leukemia, Oncology, Cancer research and Leukemia.
Internal medicine is frequently linked to Gastroenterology in her study.
Her Midostaurin study in the realm of Myeloid leukemia connects with subjects such as In patient.
Her research investigates the connection between Oncology and topics such as Disease that intersect with issues in DNA sequencing.
Her Cancer research research is multidisciplinary, relying on both Haematopoiesis, Gene expression, Gene, Gene knockdown and Progenitor cell.
Her Leukemia study deals with Randomized controlled trial intersecting with Retinoic acid.
Between 2017 and 2021, her most popular works were:
- Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party. (388 citations)
- Measurable residual disease monitoring by NGS before allogeneic hematopoietic cell transplantation in AML. (101 citations)
- Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD. (97 citations)
In her most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
Her primary areas of study are Myeloid leukemia, Internal medicine, Cancer research, Oncology and Leukemia.
Her Myeloid leukemia study incorporates themes from Germline mutation, Tp53 mutation, Variant allele, NPM1 and T.
Konstanze Döhner focuses mostly in the field of Internal medicine, narrowing it down to matters related to Gastroenterology and, in some cases, Dasatinib, Confidence interval, Toxicity and Core binding factor acute myeloid leukemia.
Her Cancer research research includes themes of Haematopoiesis, Progenitor cell and Chromatin, Gene, Gene isoform.
Her studies in Oncology integrate themes in fields like White blood cell and Gemtuzumab ozogamicin.
Her Leukemia research is multidisciplinary, incorporating perspectives in Myeloid and Randomized controlled trial.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
